Embassy In London Under Siege, IP A ‘Neo-Liberal Pillar’, Ecuador Minister Says 29/06/2016 by Catherine Saez, Intellectual Property Watch 1 Comment A top Ecuadoran official said today at the United Nations in Geneva that WikiLeaks founder Julian Assange’s health is deteriorating after four years confined in the Ecuadoran embassy in London, while the United Kingdom and Sweden are ignoring the findings of the UN Working Group on Arbitrary Detention which called for Assange’s release. The Ecuadoran Minister of Foreign Affairs also said Ecuador will carry on issuing compulsory licences for medicines as it sees fit, underlining the increasing role of intellectual property and the greater privatisation of knowledge.
IP-Watch Sample Editorial Calendar [Below is a sample of our typical annual editorial calendar] Each month will feature a general theme and a focus, or hot topic IP Watch considers opinion pieces relating to our areas of coverage. For more information on guidelines and the submission process, click here. March Theme: Patents & Standards Setting Focus: IEEE Policy April Theme: […]
OECD Ministerial On Internet Wraps Up: Openness A Concern 24/06/2016 by Monika Ermert for Intellectual Property Watch 2 Comments The Organization for Economic Cooperation and Development (OECD) should not wait 8 or 10 years before its next Internet Ministerial, said OECD Secretary General Angel Gurria at the closing session in Cancun Mexico yesterday. Gurria called for a faster pace for government and regulators to adapt to the digital markets. Better data on the data economy will help, as reflected in the new Cancun Declaration.
UK “Brexit” Leaves IP Community With Many Questions 24/06/2016 by Dugie Standeford for Intellectual Property Watch and William New 7 Comments Britons’ 23 June decision to pull out of the European Union has caused shock waves in the UK and Europe, and the vote is still being digested. Early reactions from members of the intellectual property community show that the impact of Brexit on IP policies and issues in Britain and Europe is far from clear.
Jaguar Land Rover Faces Uphill Legal Battle Against Jiangling Motor Over Copycat Car 22/06/2016 by Bruce Gain for Intellectual Property Watch Leave a Comment Jaguar Land Rover has sued carmaker Jiangling Motor in a Chinese court for allegedly copying its Evoque SUV, but observers say the solution to car clones lies outside the courtroom.
USTR Froman: IP-Related Biologics Still Key Sticking Point For TPP Passage In US 20/06/2016 by William New, Intellectual Property Watch 1 Comment United States Trade Representative Michael Froman today said biologics remain one of the biggest unresolved issues in getting the Trans-Pacific Partnership passed in the US Congress. He called biologics an intellectual property rights issue and said the administration is working with Congress and industry to resolve concerns without reopening the trade deal completed last autumn.
European Council Conclusions On Steps To Combat Antimicrobial Resistance 17/06/2016 by Intellectual Property Watch 1 Comment The 28 European Union member governments have concluded next steps for addressing antimicrobial resistance, with a strong emphasis on reducing use of antibiotics in animals, but also including a call for new business models.
Panels Brainstorm Ideas On Innovation And Drug Access 15/06/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment The quest of balance between encouraging medical innovation and the imperative of broad access to medicines has so far been elusive. Two Harvard University programmes jointly organised a workshop this week with the aim of encouraging a conversation between global health actors and see if some “outside the box” thinking is possible.
UN Development Agency Issues Guidelines For Pharmaceutical Patent Examiners 15/06/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment A new set of guidelines for pharmaceutical patent examination has been published by the United Nations Development Programme that seek to help reduce poor quality patents and ensure efficient market entry of generic products. The guidelines, written by a well-known advocate of access to medicines, aim at advising patent examiners in assessing the patentability requirements of applications relating to pharmaceutical products and processes.
More Changes In UN Agencies; Movements In Global Health 14/06/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment Movement has been happening in international organisations in recent weeks, particularly in United Nations agencies, as new executive directors were nominated, and department directorships changed hands. The private sector and non-governmental organisations also saw a number of position switches and nominations, in particular in the health sector. Law offices kept pace with the usual chair revolving.